Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhilei Wang

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
JCI Insight|December 22, 2020
Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90Guang Xu, Shubin Fu, Xiaoyan Zhan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 11, 2026
Mesoscale Recovery of Microglial and Neuronal Dynamics After Craniotomy Across Wide Cortex in Transgenic MiceGuihua Xiao, Zhilei Wang, Pengchang Zheng, et al.
Acta Pharmaceutica Sinica. B|October 22, 2020
Icariside Ⅱ, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP3 inflammasome activationZhilei Wang, Guang Xu, Hongbo Wang, et al.
Cell Death Discovery|July 9, 2022
The role of NLRP3 inflammasome in psychotropic drug-induced hepatotoxicityWenqing Mu, Guang Xu, Ziying Wei, et al.
Frontiers of Medicine|April 28, 2021
Bavachin enhances NLRP3 inflammasome activation induced by ATP or nigericin and causes idiosyncratic hepatotoxicityNan Qin, Guang Xu, Yan Wang, et al.
Frontiers in Pharmacology|June 21, 2021
The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in MiceYongqiang Ai, Wei Shi, Xiaobin Zuo, et al.
Frontiers in Pharmacology|October 25, 2021
Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis <i>via</i> Modulating Multiple Signaling Pathways in MiceYongqiang Ai, Wei Shi, Xiaobin Zuo, et al.
Neurobiology of Aging|December 12, 2018
CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61IChengyuan Mao, Herui Wang, Haiyang Luo, et al.
Journal of the American Heart Association|November 3, 2021
Risk Stratifying and Prognostic Analysis of Subclinical Cardiac Implantable Electronic Devices Infection: Insight From Traditional Bacterial CultureGaofeng Lin, Tong Zou, Min Dong, et al.
Frontiers in Pharmacology|October 22, 2021
Germacrone Attenuates Hepatic Stellate Cells Activation and Liver Fibrosis via Regulating Multiple Signaling PathwaysZhiyong Li, Zhilei Wang, Fang Dong, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
JCI Insight|December 22, 2020
Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90Guang Xu, Shubin Fu, Xiaoyan Zhan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 11, 2026
Mesoscale Recovery of Microglial and Neuronal Dynamics After Craniotomy Across Wide Cortex in Transgenic MiceGuihua Xiao, Zhilei Wang, Pengchang Zheng, et al.
Acta Pharmaceutica Sinica. B|October 22, 2020
Icariside Ⅱ, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP3 inflammasome activationZhilei Wang, Guang Xu, Hongbo Wang, et al.
Cell Death Discovery|July 9, 2022
The role of NLRP3 inflammasome in psychotropic drug-induced hepatotoxicityWenqing Mu, Guang Xu, Ziying Wei, et al.
Frontiers of Medicine|April 28, 2021
Bavachin enhances NLRP3 inflammasome activation induced by ATP or nigericin and causes idiosyncratic hepatotoxicityNan Qin, Guang Xu, Yan Wang, et al.
Frontiers in Pharmacology|June 21, 2021
The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in MiceYongqiang Ai, Wei Shi, Xiaobin Zuo, et al.
Frontiers in Pharmacology|October 25, 2021
Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis <i>via</i> Modulating Multiple Signaling Pathways in MiceYongqiang Ai, Wei Shi, Xiaobin Zuo, et al.
Neurobiology of Aging|December 12, 2018
CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61IChengyuan Mao, Herui Wang, Haiyang Luo, et al.
Journal of the American Heart Association|November 3, 2021
Risk Stratifying and Prognostic Analysis of Subclinical Cardiac Implantable Electronic Devices Infection: Insight From Traditional Bacterial CultureGaofeng Lin, Tong Zou, Min Dong, et al.
Frontiers in Pharmacology|October 22, 2021
Germacrone Attenuates Hepatic Stellate Cells Activation and Liver Fibrosis via Regulating Multiple Signaling PathwaysZhiyong Li, Zhilei Wang, Fang Dong, et al.
Pageof 10